The present invention provides methods of using compounds of formula I: or compositions thereof for the inhibition of FLT3, and the treatment of FLT3-mediated disorders.
-
Paragraph 00369-00370; 00408-00409
(2014/12/12)
IRAK INHIBITORS AND USES THEREOF
The present invention relates to compounds and methods useful for inhibiting one or more interleukin-l receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
-
Page/Page column 255-256
(2012/07/28)
More Articles about upstream products of 1019014-42-6